-
1041
-
1042
Clinical integration of germline findings from a tumor testing precision medicine program
Published 2025-01-01“…Eligibility for hereditary cancer syndrome investigation (‘germline criteria’) followed Cancer Care Ontario’s Hereditary Cancer Testing Criteria and clinical judgment. …”
Get full text
Article -
1043
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis
Published 2025-01-01Get full text
Article -
1044
Melanoma Disparities among US Hispanics: Use of the Social Ecological Model to Contextualize Reasons for Inequitable Outcomes and Frame a Research Agenda
Published 2016-01-01“…Currently, there is a paucity of literature investigating the root causes underlying these trends among Hispanics. Given that Hispanics are the most rapidly expanding demographic segment in the US, it is essential for cancer control efforts to elucidate the major determinants of their poor melanoma outcomes. …”
Get full text
Article -
1045
New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
Published 2024-11-01Get full text
Article -
1046
Urine proteomics defines an immune checkpoint-associated nephritis signature
Published 2025-01-01“…Immune checkpoint inhibitor (ICI) therapy is a cornerstone treatment for many cancers, but it can induce severe immunotoxicity, including acute interstitial nephritis (AIN). …”
Get full text
Article -
1047
An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature...
Published 2024-01-01“…Approximately half of IMTs are positive for an anaplastic lymphoma kinase (ALK) gene rearrangement which causes aberrant expression. Early phase clinical trials have demonstrated the efficacy of ALK inhibitors in the treatment of IMTs. …”
Get full text
Article -
1048
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
Published 2023-01-01Get full text
Article -
1049
Recent updates of centromere proteins in hepatocellular carcinoma: a review
Published 2025-02-01“…Abstract Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, with approximately 800,000 deaths worldwide each year. …”
Get full text
Article -
1050
Successful Diagnosis and Management of Superior Orbital Fissure Syndrome Secondary to Lung Adenocarcinoma: A Case Report
Published 2025-01-01“…It also demonstrates the efficacy of localized radiotherapy in treating such uncommon presentations of lung cancer metastasis.Keywords: superior orbital fissure syndrome, lung adenocarcinoma, metastasis, radiotherapy, case report…”
Get full text
Article -
1051
-
1052
Fractionated radiotherapy initiated at the early stage of bone metastasis is effective to prolong survival in mouse model
Published 2025-12-01“…Background and purpose Bone metastasis is common for breast cancer and associated with poor prognosis. Currently, radiotherapy (RT) serves as the standard treatment for patients exhibiting symptoms of bone metastasis to alleviate pain. …”
Get full text
Article -
1053
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Published 2024-11-01“…Recent reports suggest a correlation between ICI-induced systemic inflammation and thromboembolic events as well as an increased effectiveness by coadministration of anticoagulants. With cancer patients having a higher risk of thrombotic events per se, it is crucial to dissect and characterize the mechanisms that cause pro-coagulative effects induced by systemic tumor therapies and their potential interplay with anti-tumor response. …”
Get full text
Article -
1054
Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
Published 2025-01-01Get full text
Article -
1055
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Published 2025-01-01“…Background Polyclonal autologous T cells that are epigenetically reprogrammed through mTOR inhibition and IFN-α polarization (RAPA-201) represent a novel approach to the adoptive T cell therapy of cancer. Ex vivo inhibition of mTOR results causes a shift towards T central memory (TCM) whereas ex vivo IFN-α promotes type I cytokines, with each of these functions known to enhance the adoptive T cell therapy of cancer. …”
Get full text
Article -
1056
-
1057
-
1058
Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis
Published 2023-05-01Get full text
Article -
1059
A Review on Automatic Mammographic Density and Parenchymal Segmentation
Published 2015-01-01“…However, the exact cause(s) of breast cancer still remains unknown. …”
Get full text
Article -
1060
Efficacy Analysis of Hypofractionated Radiotherapy for Oligometastatic Tumors: A Retrospective Study
Published 2025-01-01“…Introduction Metastasis remains a major cause of death among patients with malignant tumors. …”
Get full text
Article